Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Tretinoin and Arsenic Trioxide

Research Papers that Mention the Interaction

A group of 30 patients received ATO, and another group of 37 patients received ATO plus ATRA.
Leukemia research  •  2018  |  View Paper
The largest difference, favoring patients treated with ATRA plus arsenic trioxide , was found for fatigue severity (mean score difference, -9.3; 95% CI, -17.8 to -0.7; P = .034) at end of induction therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  •  2014  |  View Paper
Our results suggest that the combination of As2O3 and ATRA might decrease the relapse rate compared with ATRA alone in induction therapy for childhood APL, at least in those with a WBC count less than 10 × 109/L.
International journal of hematology  •  2011  |  View Paper
ATRA plus ATO may serve as an alternative to chemotherapy in low-risk untreated APL (eg, in older patients) and, when combined with GO, may improve outcome in high-risk patients.
Blood  •  2006  |  View Paper
Preclinical observations have indicated that all-trans-retinoic acid (ATRA) may strongly enhance the response to ATO.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  •  2003  |  View Paper
All-trans retinoic acid and arsenic trioxide , two widely used drugs in APL therapy, exert synergistic effects on controlling super-enhancer-associated PML/RARα-regulated targets in APL cells.
Blood  •  2020  |  View Paper
Strikingly, we demonstrate that the combination of ATRA and ATO proves to be a powerfully synergistic and effective therapy in a number of mouse and human mIDH1/2 leukemic models.
Cell Research  •  2019  |  View Paper
ATRA increases cellular ATO uptake through upregulating aquaporin-9.
Here we show that ATO targets Pin1 and cooperates with ATRA to exert potent anticancer activity.
Nature Communications  •  2018  |  View Paper
Compared with the historical 5-to 10-year survival rate of 10%, the survival of patients who undergo modern …%, and for specific subsets, the improvements are even more dramatic; for example, in acute promyelocytic leukemia, the use of all-trans retinoic acid … arsenic trioxide improved survival from … to 90%.
Critical reviews in oncology/hematology  •  2017  |  View Paper
Moreover, addition of ATO , an agent that induces oxidative stress and interferes with protein translation, to ATRA sharply increases APL cell killing to the extent that cures in this disease are no longer unrealistic.
Blood  •  2015  |  View Paper
Show More